Abstract 7592: Machine learning enables accurate prediction of patient outcomes for immune checkpoint blockade using real-world clinical data.

Le résumé fourni par la source

Abstract Background: While immune checkpoint blockade (ICB) therapy can produce durable clinical responses and substantially improve patient outcomes, accurate predictors of outcomes are critical as up to half of patients with advanced disease derive limited or no benefit. Accurate ICB outcome prediction will improve treatment stratification, reduce unnecessary toxicity, and enhance outcomes for cancer patients. Methods: We used state-of-the-art machine learning survival models to accurately predict patient survival after ICB therapy in our large multi-cancer institutional cohort. This retrospective study included 2,090 patients with advanced melanoma (n=908), advanced non-small cell lung cancer (NSCLC, n=878), or metastatic renal cell carcinoma (RCC, n=304) who underwent anti-PD-1/PD-L1 and/or anti-CTLA-4 ICB therapy at Moffitt Cancer Center from 2011-2025. Over 50 pre-treatment clinical and laboratory features were abstracted from electronic health records and analyzed against overall and progression-free survival. We trained and tested survival support vector machine models to predict patient outcomes with a 75/25 random split. Results: Cox PH analysis identified 11-44 statistically significant features per data set for inclusion into each model, including serum albumin, neutrophil-to-lymphocyte ratio, blood pressure, heart rate, and ECOG scores. Our models achieved AUC values of up to 0.83 in melanoma, 0.80 in NSCLC, and 0.85 in RCC, with enhanced performance in progression models trained on multi-cancer data. Our models outperformed PD-L1 and TMB at each time point where data is available. Conclusions: Our work demonstrates the promise of machine learning with accessible clinical and laboratory features to predict ICB patient outcomes with improved performance versus current biomarkers. Citation Format: Alyssa Pybus, Isis Yanina Narvaez-Bandera, Tosin Jolaogun, PAULO CILAS MORAIS LYRA JR, Khai Dang, Jeremy Goecks, . Machine learning enables accurate prediction of patient outcomes for immune checkpoint blockade using real-world clinical data [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2026; Part 1 (Regular Abstracts); 2026 Apr 17-22; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2026;86(7 Suppl):Abstract nr 7592.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.